van Wamelen Daniel Johannes, Rota Silvia, Schrag Anette, Rizos Alexandra, Martinez-Martin Pablo, Weintraub Daniel, Ray Chaudhuri Kallol
Division of Neuroscience, Department of Basic & Clinical Neuroscience, King's College London Institute of Psychiatry, Psychology & Neuroscience London United Kingdom.
Parkinson Foundation Centre of Excellence at King's College Hospital NHS Foundation Trust London United Kingdom.
Mov Disord Clin Pract. 2022 Aug 5;9(7):932-940. doi: 10.1002/mdc3.13520. eCollection 2022 Oct.
Non-motor fluctuations (NMF) in people with Parkinson's disease (PwP) are clinically important yet understudied.
To study NMF in PwP using both the Movement Disorder Society Non-Motor Rating Scale (MDS-NMS) NMF subscale and wearable sensors.
We evaluated differences in overall burden of NMF and of specific NMF across disease durations: <2 years (n = 33), 2-5 years (n = 35), 5-10 years (n = 33), and > 10 years (n = 31). In addition, wearable triaxial sensor output was used as an exploratory outcome for early morning "off" periods.
Significant between-group differences were observed for MDS-NMS NMF total scores ( < 0.001), and specifically for depression, anxiety, fatigue and cognition, with both NMF prevalence and burden increasing in those with longer disease duration. Whereas only 9.1% with a short disease duration had NMF (none of whom had dyskinesia), in PwP with a disease duration of >10 years this was 71.0% ( < 0.001). From a motor perspective, dyskinesia severity increased evenly with increasing disease duration, while NMF scores in affected individuals showed an initial increase with largest differences between 2-5 years disease duration ( < 0.001), with plateauing afterwards. Finally, we observed that the most common NMF symptoms in patients with sensor-confirmed early morning "off" periods were fluctuations in cognitive capabilities, restlessness, and excessive sweating.
Non-motor fluctuations prevalence in PwP increases with disease duration, but in a pattern different from motor fluctuations. Moreover, NMF can occur in PwP without dyskinesia, and in those with NMF the severity of NMF increases most during years 2-5 after diagnosis.
帕金森病患者的非运动波动(NMF)在临床上很重要,但研究较少。
使用运动障碍协会非运动评定量表(MDS-NMS)的NMF子量表和可穿戴传感器研究帕金森病患者的NMF。
我们评估了不同病程(<2年,n = 33;2 - 5年,n = 35;5 - 10年,n = 33;>10年,n = 31)的NMF总体负担及特定NMF的差异。此外,可穿戴三轴传感器输出被用作清晨“关”期的探索性结果。
观察到MDS-NMS NMF总分存在显著组间差异(<0.001),特别是在抑郁、焦虑、疲劳和认知方面,随着病程延长,NMF的患病率和负担均增加。病程短的患者中只有9.1%有NMF(均无异动症),而病程>10年的帕金森病患者中这一比例为71.0%(<0.001)。从运动角度看,异动症严重程度随病程延长均匀增加,而受影响个体的NMF评分最初增加,在病程2 - 5年时差异最大(<0.001),之后趋于平稳。最后,我们观察到传感器确认的清晨“关”期患者中最常见的NMF症状是认知能力波动、烦躁不安和多汗。
帕金森病患者的非运动波动患病率随病程增加,但模式与运动波动不同。此外,无异动症的帕金森病患者也可出现NMF,且有NMF的患者在诊断后2 - 5年NMF严重程度增加最多。